Financials HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 04:00:05 2024-05-16 pm EDT			5-day change	1st Jan Change
322.7 ^USD	-1.30%		+0.25%	+19.22%

May. 14	DBS Bank Initiates HCA Healthcare at Buy Rating With $370 Price Target	MT
May. 13	Hca Healthcare Insider Sold Shares Worth $516,450, According to a Recent SEC Filing	MT

Valuation

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	50,134	55,649	79,908	67,841	72,450	85,635	-	-
Enterprise Value (EV) ¹	83,235	84,860	113,036	105,017	111,108	126,613	125,301	125,945
P/E ratio	14.7 x	15 x	12.1 x	12.5 x	14.3 x	15.7 x	14.2 x	12.8 x
Yield	1.1%	0.26%	0.75%	0.93%	-	0.81%	0.86%	0.91%
Capitalization / Revenue	0.98 x	1.08 x	1.36 x	1.13 x	1.12 x	1.23 x	1.17 x	1.11 x
EV / Revenue	1.62 x	1.65 x	1.92 x	1.74 x	1.71 x	1.82 x	1.71 x	1.63 x
EV / EBITDA	8.44 x	8.45 x	8.94 x	8.7 x	8.73 x	9.51 x	8.92 x	8.48 x
EV / FCF	24.2 x	13.3 x	21 x	33.9 x	23.7 x	27.7 x	27.8 x	25.3 x
FCF Yield	4.14%	7.54%	4.76%	2.95%	4.22%	3.62%	3.6%	3.95%
Price to Book	-18.3 x	98.8 x	-90.5 x	-25.6 x	-	-39 x	-130 x	192 x
Nbr of stocks (in thousands)	339,178	338,375	311,023	282,717	267,661	261,914	-	-
Reference price ²	147.8	164.5	256.9	240.0	270.7	327.0	327.0	327.0
Announcement Date	1/28/20	2/2/21	1/27/22	1/27/23	1/30/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	51,336	51,533	58,752	60,233	64,968	69,484	73,233	77,200
EBITDA ¹	9,857	10,037	12,644	12,067	12,726	13,310	14,047	14,852
EBIT ¹	7,261	7,316	9,791	9,098	9,649	10,095	10,662	11,256
Operating Margin	14.14%	14.2%	16.66%	15.1%	14.85%	14.53%	14.56%	14.58%
Earnings before Tax (EBT) ¹	5,244	5,430	9,833	8,580	7,706	8,125	8,563	9,129
Net income ¹	3,505	3,754	6,956	5,643	5,242	5,518	5,910	6,321
Net margin	6.83%	7.28%	11.84%	9.37%	8.07%	7.94%	8.07%	8.19%
EPS ²	10.07	10.93	21.16	19.15	18.97	20.84	22.96	25.55
Free Cash Flow ¹	3,444	6,397	5,382	3,102	4,687	4,578	4,511	4,972
FCF margin	6.71%	12.41%	9.16%	5.15%	7.21%	6.59%	6.16%	6.44%
FCF Conversion (EBITDA)	34.94%	63.73%	42.57%	25.71%	36.83%	34.39%	32.11%	33.47%
FCF Conversion (Net income)	98.26%	170.4%	77.37%	54.97%	89.41%	82.97%	76.32%	78.65%
Dividend per Share ²	1.630	0.4300	1.920	2.240	-	2.647	2.811	2.960
Announcement Date	1/28/20	2/2/21	1/27/22	1/27/23	1/30/24	-	-	-

¹USD in Million²USD

Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2
Net sales ¹	15,064	14,945	14,820	14,971	15,497	15,591	15,861	16,213	17,303	17,339	17,030	17,183	18,190	18,183	18,000
EBITDA ¹	3,149	2,944	3,042	2,902	3,179	3,172	3,056	2,880	3,618	3,353	3,229	3,063	3,697	3,520	3,417
EBIT ¹	2,421	2,212	2,304	2,153	2,429	2,416	2,293	2,111	2,829	2,558	2,420	2,271	2,853	2,690	2,573
Operating Margin	16.07%	14.8%	15.55%	14.38%	15.67%	15.5%	14.46%	13.02%	16.35%	14.75%	14.21%	13.22%	15.68%	14.79%	14.3%
Earnings before Tax (EBT) ¹	2,586	1,814	1,760	1,704	3,302	1,922	1,809	1,630	2,345	2,247	1,921	1,757	2,360	2,164	2,022
Net income ¹	1,814	1,273	1,155	1,134	2,081	1,363	1,193	1,079	1,607	1,591	1,305	1,184	1,584	1,510	1,425
Net margin	12.04%	8.52%	7.79%	7.57%	13.43%	8.74%	7.52%	6.66%	9.29%	9.18%	7.66%	6.89%	8.71%	8.3%	7.92%
EPS ²	5.750	4.140	3.900	3.910	7.280	4.850	4.290	3.910	5.930	5.930	4.891	4.492	6.116	5.869	5.575
Dividend per Share ²	0.4800	0.5600	0.5600	0.5600	0.5600	0.6000	0.6000	0.6000	-	-	0.6570	0.6575	0.6680	0.7120	0.7119
Announcement Date	1/27/22	4/22/22	7/22/22	10/21/22	1/27/23	4/21/23	7/27/23	10/24/23	1/30/24	4/26/24	-	-	-	-	-

¹USD in Million²USD

Estimates

Balance Sheet Analysis

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	33,101	29,211	33,128	37,176	38,658	40,977	39,665	40,309
Net Cash position ¹	-	-	-	-	-	-	-	-
Leverage (Debt/EBITDA)	3.358 x	2.91 x	2.62 x	3.081 x	3.038 x	3.079 x	2.824 x	2.714 x
Free Cash Flow ¹	3,444	6,397	5,382	3,102	4,687	4,578	4,511	4,972
ROE (net income / shareholders' equity)	-	-	352%	-	-	122%	58.6%	39.1%
ROA (Net income/ Total Assets)	8.32%	8.11%	14.2%	10.9%	9.46%	9.33%	10.4%	10.5%
Assets ¹	42,127	46,274	49,116	51,590	55,400	59,131	57,079	60,444
Book Value Per Share ²	-8.060	1.660	-2.840	-9.390	-	-8.380	-2.520	1.700
Cash Flow per Share ²	21.80	26.90	27.30	28.90	34.10	36.70	37.10	39.20
Capex ¹	4,158	2,835	3,577	4,395	4,744	5,131	5,340	5,628
Capex / Sales	8.1%	5.5%	6.09%	7.3%	7.3%	7.38%	7.29%	7.29%
Announcement Date	1/28/20	2/2/21	1/27/22	1/27/23	1/30/24	-	-	-

¹USD in Million²USD

Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for HCA Healthcare, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

322.7 USD

Average target price

344.4 USD

Spread / Average Target

+6.71%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
HCA HEALTHCARE, INC.	+19.22%	85.64B
CVS HEALTH CORPORATION	-27.14%	70.63B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+4.65%	27.05B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-6.23%	17.97B
FRESENIUS SE & CO. KGAA	+1.60%	17.58B
QUEST DIAGNOSTICS INCORPORATED	+3.30%	15.64B
REDE D'OR SÃO LUIZ S.A.	+7.44%	13.55B
FRESENIUS MEDICAL CARE AG	+9.91%	13.41B
NATERA, INC.	+73.32%	13.18B
TENET HEALTHCARE CORPORATION	+69.26%	12.99B

Other Healthcare Facilities & Services